Tag: MDD
Magnus announces first treatments in OLO clinical trial of novel depression...
Magnus Medical has announced that the first participants have been treated in the Open Label Optimisation (OLO) clinical trial evaluating the effectiveness of the...
Interim analysis of MOOD trial produces positive neuromodulation data in depression...
Neurolief has announced positive results from a planned interim analysis of the ongoing, randomised controlled MOOD pivotal trial, which is studying Relivion DP—a novel...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
Magnus shares study results indicating SAINT depression treatment changes abnormal brain...
Magnus Medical has shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT neuromodulation...
